InvestorsHub Logo
Followers 0
Posts 341
Boards Moderated 0
Alias Born 06/05/2019

Re: None

Monday, 01/08/2024 12:06:40 PM

Monday, January 08, 2024 12:06:40 PM

Post# of 3059
Could the Mgt surprise us with partnership news ? Enanta plans to pursue any future COVID-19 efforts in the context of a collaboration, including the development of EDP-235, an oral, once-daily, Phase-3-ready, 3CL protease inhibitor which has been granted Fast Track designation by the FDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News